TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid

Conditions:   Myelodysplastic Syndromes;   Myeloproliferative Neoplasm;   Acute Myeloid Leukemia Interventions:   Drug: Azacitidine;   Drug: Ascorbic acid Sponsor:   Case Comprehensive Cancer Center Not yet recruiting

Source: ClinicalTrials.gov - January 11, 2018 Category: Research Source Type: clinical trials